Torrent Pharmaceuticals Ltd.

TORNTPHARM

₹3194.9

3.55% (109.65)

Market Cap

₹1,08,006 Cr.

P/E

62.25

About

Torrent Pharmaceuticals Limited is a prominent player in the Indian Pharma industry, with specialized marketing divisions focusing on cardiovascular, central nervous system, gastro-intestinal, and wom… Read more

Torrent Pharmaceuticals Limited is a prominent player in the Indian Pharma industry, with spec… Read more

Low

1772

52W Range

High

3257

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Forensics

12 Yes

Positive for this company

1 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE

Latest

24.16%

3yr Average

19.1%

5yr Average

20.0%

Net Profit Margin

Latest

15.44%

3yr Average

12.51%

5yr Average

13.21%

ROCE

Latest

28.82%

3yr Average

25.66%

5yr Average

23.72%

Debt to Equity

Latest

0.57

3yr Average

0.7

5yr Average

0.83

Market Share

3.16 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.84 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.74 %

(as of Nov 21)

Historic

Anti-Malarial - Market Share

0.27 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

0.26 %

(as of Nov 21)

Historic

Blood Related - Market Share

7.22 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

1.22 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.01 %

(as of May 21)

Historic

Endocrinology - Market Share

4.93 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

1.50 %

(as of Nov 21)

Historic

Gynecology - Market Share

20 %

(as of Mar 19)

Source/Historic

Losartan & Lamtrigine - Market Share in Brazil

7.53 %

(as of Nov 21)

Historic

Neurological - Market Share

0.01 %

(as of Mar 18)

Historic

Ophthalmology - Market Share

3.05 %

(as of Nov 21)

Historic

Pain - Market Share

3.40 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

0.19 %

(as of Nov 21)

Historic

Respiratory - Market Share

0 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

30 %

(as of Mar 19)

Source/Historic

Shelcal - Market Share

34.62 %

(as of May 19)

Historic

Stomatological - Market Share

0.40 %

(as of Nov 21)

Historic

Urology - Market Share

4.78 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Acute vs Chronic

Asset Break-Up

Operational Metrics

Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Losar

Shelcal

Suppliers

Aarti Drugs Ltd.
PSP Projects Ltd.
Allcargo Gati Ltd.
Gulshan Polyols Ltd.
Sayaji Industries Ltd.

FAQs on Torrent Pharmaceuticals Ltd. Business

What does Torrent Pharma do?

Torrent Pharmaceuticals Limited is a leading company in the Indian Pharma industry, specializing in cardiovascular, CNS, gastro-intestinal, and women healthcare. With the acquisition of Unichem's domestic business, it has risen to become the 8th largest pharma firm in India.

Who are the competitors of Torrent Pharma?

Torrent Pharma major competitors are Dr. Reddy's Lab, Cipla, Zydus Lifesciences, Mankind Pharma, Lupin, Aurobindo Pharma, Alkem Laboratories.
Market Cap of Torrent Pharma is ₹1,08,006 Crs.
While the median market cap of its peers are ₹83,886 Crs.

Is Torrent Pharma financially stable compared to its peers?

Torrent Pharma seems to be less financially stable compared to its peers.
Altman Z score of Torrent Pharma is 10.44 and is ranked 5 out of its 8 competitors.

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Jun	Dec	Jun	Mar Jun Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec